N-(3-Methyl-4-(6-methylimidazo[1,2-a]pyrazin-5-yl)phenyl)furo-[3,2-c]pyridin-4-amine

ID: ALA4475848

PubChem CID: 146025704

Max Phase: Preclinical

Molecular Formula: C21H17N5O

Molecular Weight: 355.40

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1cc(Nc2nccc3occc23)ccc1-c1c(C)ncc2nccn12

Standard InChI:  InChI=1S/C21H17N5O/c1-13-11-15(25-21-17-6-10-27-18(17)5-7-23-21)3-4-16(13)20-14(2)24-12-19-22-8-9-26(19)20/h3-12H,1-2H3,(H,23,25)

Standard InChI Key:  GNZMEDWGRFHELH-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 31  0  0  0  0  0  0  0  0999 V2000
    3.8298   -7.8155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5395   -7.4061    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5366   -6.5834    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.8280   -6.1782    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1217   -7.4066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1230   -6.5900    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3468   -6.3365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8658   -6.9964    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3448   -7.6576    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.8242   -5.3610    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5301   -4.9491    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2375   -5.3593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9428   -4.9481    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.9395   -4.1300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2249   -3.7249    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.5225   -4.1384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.2183   -2.9077    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6448   -3.7172    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3521   -4.1231    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.0569   -3.7110    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.0525   -2.8930    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6355   -2.9032    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.3365   -2.4945    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.1644   -1.7015    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.3570   -1.6201    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0303   -2.3628    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3554   -4.9403    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  5  1  1  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  6  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9  5  1  0
  4 10  1  0
 10 11  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 15 17  1  0
 14 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 23  1  0
 22 18  1  0
 22 23  1  0
 23 24  2  0
 24 25  1  0
 25 26  2  0
 26 22  1  0
 19 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4475848

    ---

Associated Targets(Human)

DRD1 Tclin Dopamine D1 receptor (9720 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 355.40Molecular Weight (Monoisotopic): 355.1433AlogP: 4.90#Rotatable Bonds: 3
Polar Surface Area: 68.25Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.63CX LogP: 2.73CX LogD: 2.73
Aromatic Rings: 5Heavy Atoms: 27QED Weighted: 0.50Np Likeness Score: -0.95

References

1. Martini ML, Liu J, Ray C, Yu X, Huang XP, Urs A, Urs N, McCorvy JD, Caron MG, Roth BL, Jin J..  (2019)  Defining Structure-Functional Selectivity Relationships (SFSR) for a Class of Non-Catechol Dopamine D1 Receptor Agonists.,  62  (7): [PMID:30875219] [10.1021/acs.jmedchem.9b00351]

Source